PREREQUISITES FOR PHASE-I AND PHASE-II OF DRUG CLINICAL-TRIALS

被引：0

作者：

JAILLON, P ^{[1
]}

DUPUIS, B ^{[1
]}

机构：

[1] CTR HOSP REG & UNIV LILLE,SERV PHARMACOL HOSP,F-59037 LILLE,FRANCE

来源：

ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX | 1989年 / 82卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1773 / 1776

页数：4

共 50 条

[1] PHASE-I AND PHASE-II OF THE CLINICAL-TRIALS FOR A NEW ANTIARRHYTHMIC DRUG
JAILLON, P
THERAPIE, 1986, 41 (02): : 81 - 86
[2] PHASE-I, PHASE-II CLINICAL-TRIALS WITH CARCINOMA OF THE PANCREAS
GARCES, R
SCANLON, E
PRASAD, SG
KHANDEKAR, JD
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (10): : 1828 - 1828
[3] THE DESIGN OF PHASE-I AND PHASE-II CLINICAL-TRIALS IN CANCER - A STATISTICIANS VIEW
GELLER, NL
BIOMETRICS, 1984, 40 (04) : 1189 - 1190
[4] DESIGN OF PHASE-I AND PHASE-II CLINICAL-TRIALS IN CANCER - A STATISTICIANS VIEW
GELLER, NL
CANCER INVESTIGATION, 1984, 2 (06) : 483 - 491
[5] DESIGN OF PHASE-I AND PHASE-II CLINICAL-TRIALS IN CANCER - A STATISTICIANS VIEW
DECOSTER, G
CAVALLI, F
CANCER INVESTIGATION, 1987, 5 (06) : 649 - 650
[6] BIOLOGIC EFFECTS AND SAFETY OF STAVUDINE - OVERVIEW OF PHASE-I AND PHASE-II CLINICAL-TRIALS
SKOWRON, G
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 : S113 - S117
[7] REMISSION IN PHASE-II AND PHASE-III CLINICAL-TRIALS - CRITERIA AND PREREQUISITES
EDLER, L
FLECHTNER, H
ONKOLOGIE, 1987, 10 (06): : 330 - 339
[8] PHASE-I AND PHASE-II CLINICAL-TRIALS WITH VICOA INDICA (BANJAURI), A HERBAL MEDICINE, AS AN ANTIFERTILITY AGENT
DHALL, K
DOGRA, M
CONTRACEPTION, 1988, 37 (01) : 75 - 84
[9] PHASE-I CLINICAL-TRIALS IN DERMATOLOGY
CZERNIELEWSKI, J
QUEILIEROUSSEL, C
DUTEIL, L
VERSCHOORE, M
SCHAEFER, H
REVUZ, J
DEPROST, Y
GUILLAUME, JC
ORTONNE, JP
THERAPIE, 1991, 46 (03): : 183 - 187
[10] ETHICS OF PHASE-I CLINICAL-TRIALS
CAPRON, AM
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (07): : 882 - 883

← 1 2 3 4 5 →